{"nct_id":"NCT02988817","title":"Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors","status":"COMPLETED","status_verified_date":"2023-07","start_date":"2016-11-23","start_date_type":"ACTUAL","primary_completion_date":"2021-11-12","primary_completion_date_type":"ACTUAL","completion_date":"2021-11-12","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["GMAB"]}